Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, September 21, 2023
Immutep Limited, a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, announced the regulatory authorization of eftilagimod alpha manufactured at commercial 2,000L scale for use in clinical ...
read more
Thursday, September 21, 2023
Simulations Plus, a provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, announced it has been awarded a new funded grant from the FDA.
read more
Wednesday, September 20, 2023
Future Fields, a biotechnology company that has built the world’s first synthetic biology system to use fruit flies for recombinant protein production, announced the launch of its contract development and manufacturing organization (CDMO) service.
read more
Wednesday, September 20, 2023
Emmes, a global, full-service Clinical Research Organization (CRO) announced that Peter Ronco has been named Chief Executive Officer.
read more
Wednesday, September 20, 2023
Microbiologics has announced an expansion of their Biosafety Level 3 laboratory spaces at the company’s Global Virology Center in San Diego, California. Biological Safety Levels (BSL) are ranked from BSL-1 representing the lowest risk pathogens such ...
read more
Tuesday, September 19, 2023
Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced that the company has hired Benedikt von Braunmuehl as Chief Executive Officer (CEO).
read more
Monday, September 18, 2023
Kindeva Drug Delivery, a global drug delivery device contract development and manufacturing organization (CDMO), announced that Brian Schubmehl has joined the company as Chief Human Resources Officer.
read more
Monday, September 18, 2023
Astrea Bioseparations, a provider of bioseparation and purification technologies announced the expansion of its manufacturing and warehousing capabilities in the US. The increased capacity reflects growing demand for the Company’s chromatography ...
read more
Friday, September 15, 2023
Worldwide Clinical Trials, a full-service contract research organization (CRO), announced its Early Phase Clinical Pharmacology Unit (CPU) has been awarded accreditation from the College of American Pathologists (CAP).
read more
Friday, September 15, 2023
Jubilant HollisterStier Contract Manufacturing announced the appointment of Ian Fuller as the new Vice President of Operations.
read more
Friday, September 15, 2023
Johnson & Johnson updated its brand and uniting both its medtech and pharmaceutical segments under the Johnson & Johnson brand name to demonstrate its collective power in healthcare.
read more
Friday, September 15, 2023
CordenPharma announced the inauguration of increased commercial peptide production capacity with newly-upgraded facilities at CordenPharma Colorado, the largest Solid-Phase Peptide Synthesis (SPPS) Manufacturing facility worldwide.
read more
Friday, September 15, 2023
Charles River Laboratories International, Inc. and Related Sciences, a data science-driven drug discovery firm, announced a multi-program collaboration agreement to apply Logica™ across several previously undrugged targets in the RS portfolio.
read more
Wednesday, September 13, 2023
Torx Software Limited, announces a collaboration with CDD Vault to facilitate the seamless synthesis and registration of new compounds during the small-molecule drug discovery process.
read more
Wednesday, September 13, 2023
Kuano, a drug discovery company combining quantum mechanics with AI to design the next generation of medicines, today announced the close of its £1.8M seed funding round, led by Mercia Ventures, and including ACF Investors, Ascension Ventures, o2h ...
read more